BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 22488219)

  • 41. Need for an accurate molecular diagnosis to assess the donor origin of leukemia relapse after allogeneic stem cell transplantation.
    Spinelli O; Giussani U; Borleri G; Lazzari M; Michelato A; Dotti G; Barbui T; Rambaldi A
    Haematologica; 2000 Nov; 85(11):1153-7. PubMed ID: 11064467
    [TBL] [Abstract][Full Text] [Related]  

  • 42. HLA-C and HLA-DQB1 compatibility in unrelated cord blood transplants.
    Elia L; Arcese W; Torello M; Iori AP; Guglielmi C; Perrone MP; Screnci M; Sprovieri T; Rapanotti MC; Cimino G
    Haematologica; 1999 Jun; 84(6):530-4. PubMed ID: 10366797
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Expression patterns of costimulatory molecules on cells derived from human hematological malignancies.
    Zheng Z; Takahashi M; Aoki S; Toba K; Liu A; Osman Y; Takahashi H; Tsukada N; Suzuki N; Nikkuni K; Furukawa T; Koike T; Aizawa Y
    J Exp Clin Cancer Res; 1998 Sep; 17(3):251-8. PubMed ID: 9894758
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Recognition of clonogenic leukemic cells, remission bone marrow and HLA-identical donor bone marrow by CD8+ or CD4+ minor histocompatibility antigen-specific cytotoxic T lymphocytes.
    Faber LM; van der Hoeven J; Goulmy E; Hooftman-den Otter AL; van Luxemburg-Heijs SA; Willemze R; Falkenburg JH
    J Clin Invest; 1995 Aug; 96(2):877-83. PubMed ID: 7635982
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Conflicting HLA assignment by three different typing methods due to the apparent loss of heterozygosity in the MHC region.
    Linjama T; Impola U; Niittyvuopio R; Kuittinen O; Kaare A; Rimpiläinen J; Volin L; Peräsaari J; Jaatinen T; Lauronen J; Saarinen T; Juvonen E; Partanen J; Koskela S
    HLA; 2016 May; 87(5):350-5. PubMed ID: 26969202
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Absence of class II-associated invariant chain peptide on leukemic blasts of patients promotes activation of autologous leukemia-reactive CD4+ T cells.
    van Luijn MM; van den Ancker W; Chamuleau ME; Zevenbergen A; Westers TM; Ossenkoppele GJ; van Ham SM; van de Loosdrecht AA
    Cancer Res; 2011 Apr; 71(7):2507-17. PubMed ID: 21310823
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Matched unrelated donor marrow transplantation in patients with advanced acute leukemia.
    Greinix HT; Reiter E; Schulenburg A; Keil F; Lechner K; Fischer G; Rosenmayr A; Leitner G; Kalhs P
    Bone Marrow Transplant; 1998 Dec; 22 Suppl 4():S53-6. PubMed ID: 9916636
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Graft rejection and hyperacute graft-versus-host disease in stem cell transplantation from non-inherited maternal-antigen-complementary HLA-mismatched siblings.
    Okumura H; Yamaguchi M; Kotani T; Sugimori N; Sugimori C; Ozaki J; Kondo Y; Yamazaki H; Chuhjo T; Takami A; Ueda M; Ohtake S; Nakao S
    Eur J Haematol; 2007 Feb; 78(2):157-60. PubMed ID: 17313562
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Single nucleotide polymorphism microarray analysis of karyotypically normal acute myeloid leukemia reveals frequent copy number neutral loss of heterozygosity.
    Tyybäkinoja A; Elonen E; Vauhkonen H; Saarela J; Knuutila S
    Haematologica; 2008 Apr; 93(4):631-2. PubMed ID: 18379011
    [No Abstract]   [Full Text] [Related]  

  • 50. Quantitative analysis of somatically acquired and constitutive uniparental disomy in gastrointestinal cancers.
    Torabi K; Erola P; Alvarez-Mora MI; Díaz-Gay M; Ferrer Q; Castells A; Castellví-Bel S; Milà M; Lozano JJ; Miró R; Ried T; Ponsa I; Camps J
    Int J Cancer; 2019 Feb; 144(3):513-524. PubMed ID: 30350313
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Transformation of myelodysplastic syndromes into acute myeloid leukemias.
    Shi J; Shao ZH; Liu H; Bai J; Cao YR; He GS; Tu MF; Wang XL; Hao YS; Yang TY; Yang CL
    Chin Med J (Engl); 2004 Jul; 117(7):963-7. PubMed ID: 15265365
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Concurrent acute myeloid leukemia with inv(16)(p13.1q22) and chronic lymphocytic leukemia: molecular evidence of two separate diseases.
    Lu CM; Murata-Collins JL; Wang E; Siddiqi I; Lawrence H
    Am J Hematol; 2006 Dec; 81(12):963-8. PubMed ID: 16917916
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Alternative donors hematopoietic stem cells transplantation for adults with acute myeloid leukemia: Umbilical cord blood or haploidentical donors?
    Ruggeri A; Ciceri F; Gluckman E; Labopin M; Rocha V;
    Best Pract Res Clin Haematol; 2010 Jun; 23(2):207-16. PubMed ID: 20837332
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Clinical impact of leukemic blast heterogeneity at diagnosis in cytogenetic intermediate-risk acute myeloid leukemia.
    Hoffmann MH; Klausen TW; Boegsted M; Larsen SF; Schmitz A; Leinoe EB; Schmiegelow K; Hasle H; Bergmann OJ; Sorensen S; Nyegaard M; Dybkaer K; Johnsen HE
    Cytometry B Clin Cytom; 2012 May; 82(3):123-31. PubMed ID: 22328535
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Somatic mutation in the two HLA-B genes of a patient with acute myelogenous leukemia.
    Balas A; Planelles D; Goterris R; Rodríguez-Cebriá M; Vicario JL
    HLA; 2019 Oct; 94(4):360-364. PubMed ID: 31338977
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Interstitial uniparental isodisomy at clustered breakpoint intervals is a frequent mechanism of NF1 inactivation in myeloid malignancies.
    Stephens K; Weaver M; Leppig KA; Maruyama K; Emanuel PD; Le Beau MM; Shannon KM
    Blood; 2006 Sep; 108(5):1684-9. PubMed ID: 16690971
    [TBL] [Abstract][Full Text] [Related]  

  • 57. False homozygosity results in HLA genotyping due to loss of chromosome 6 in a patient with acute lymphoblastic leukemia.
    Park H; Hyun J; Park SS; Park MH; Song EY
    Korean J Lab Med; 2011 Oct; 31(4):302-6. PubMed ID: 22016688
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Segmental uniparental disomy as a recurrent mechanism for homozygous CEBPA mutations in acute myeloid leukemia.
    Wouters BJ; Sanders MA; Lugthart S; Geertsma-Kleinekoort WM; van Drunen E; Beverloo HB; Löwenberg B; Valk PJ; Delwel R
    Leukemia; 2007 Nov; 21(11):2382-4. PubMed ID: 17554374
    [No Abstract]   [Full Text] [Related]  

  • 59. Regions of acquired uniparental disomy at diagnosis of follicular lymphoma are associated with both overall survival and risk of transformation.
    O'Shea D; O'Riain C; Gupta M; Waters R; Yang Y; Wrench D; Gribben J; Rosenwald A; Ott G; Rimsza LM; Holte H; Cazier JB; Johnson NA; Campo E; Chan WC; Gascoyne RD; Young BD; Staudt LM; Lister TA; Fitzgibbon J
    Blood; 2009 Mar; 113(10):2298-301. PubMed ID: 19141865
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Genome-Wide Profiling of Acquired Uniparental Disomy Reveals Prognostic Factors in Head and Neck Squamous Cell Carcinoma.
    Tuna M; Liu W; Amos CI; Mills GB
    Neoplasia; 2019 Nov; 21(11):1102-1109. PubMed ID: 31734631
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.